Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway

Basic Research in Cardiology

Volumn 107, Issue 2, 2012, Pages

  Parajuli, Nirmal ^a   Yuan, Yuan ^b   Zheng, Xiaoxu ^a   Bedja, Djahida ^a   Cai, Zheqing P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 10; Metalloproteinase; Myocardial infarction; Tumor necrosis factor a; Ventricular remodeling

Indexed keywords

ADENOVIRUS VECTOR; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INACTIVATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HEART INFARCTION; HETEROZYGOSITY; MOUSE; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION; WILD TYPE;

EID: 84856314612     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0248-6     Document Type: Article

References (57)

1. American Heart Association (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123:e18-e209. doi:10.1161/CIR.0b013e3182 009701
2. Barrett JS, Wagner JG, Fisher SJ, Wahl RL (1991) Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat. Cancer Res 51:3434-3444
3. Benkhart EM, Siedlar M, Wedel A, Werner T, Ziegler-Heitbrock HW (2000) Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J Immunol 165:1612-1617 (Pubitemid 30604599)
4. Burchfield JS, Iwasaki M, Koyanagi M, Urbich C, Rosenthal N, Zeiher AM, Dimmeler S (2008) Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 103:203-211. doi:10.1161/ CIRCRESAHA.108.178475
5. Cai ZP, Shen Z, Van Kaer L, Becker LC (2008) Ischemic preconditioning- induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J 22:4248-4257. doi:10.1096/fj.08-105940
6. Cao W, Xie YH, Li XQ, Zhang XK, Chen YT, Kang R, Chen X, Miao S, Wang SW (2011) Burn-induced apoptosis of cardiomyocytes is survivin dependent and regulated by PI3 K/Akt, p38 MAPK and ERK pathways. Basic Res Cardiol 106:1207-1220. doi:10.1007/s00395-011-0199-3
7. Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N (2010) FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol 105:301-313. doi:10.1007/s00395-009-0046-y
8. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM (2002) Regulation of myocardial contractility and cell size by distinct PI3 K-PTEN signaling pathways. Cell 110:737-749. doi:10.1016/S0092-8674(02)00969-8 (Pubitemid 35283963)
9. Deten A, Volz HC, Briest W, Zimmer HG (2002) Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 55:329-340. doi:10.1016/S0008-6363(02)00413-3 (Pubitemid 34775283)
10. Dhingra S, Sharma AK, Singla DK, Singal PK (2007) p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. Am J Physiol 293:H3524-H3531. doi:10.1152/ajpheart. 00919.2007 (Pubitemid 350230896)
11. Dörge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, Heusch G (2002) Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol 34:51-62. doi:10.1006/jmcc.2001.1489 (Pubitemid 34146395)
12. Fan WJ, van Vuuren D, Genade S, Lochner A (2010) Kinases and phosphatases in ischaemic preconditioning: a re-evaluation. Basic Res Cardiol 105:495-511. doi:10.1007/s00395-010-0086-3
13. Frangogiannis NG (2006) The mechanistic basis of infarct healing. Antioxid Redox Signal 8:1907-1939. doi:10.1089/ars.2006. 8.1907 (Pubitemid 46504897)
14. Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML (2000) IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol 165:2798-2808 (Pubitemid 30660731)
15. Garlie JB, Hamid T, Gu Y, Ismahil MA, Chandrasekar B, Prabhu SD (2011) Tumor necrosis factor receptor 2 signaling limits b-adrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Res Cardiol 106:1193-1205. doi:10.1007/s00395-011- 0196-6
16. Guha M, Mackman N (2002) The phosphatidylinositol 3-kinase- Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277:32124-32132. doi:10.1074/jbc. M203298200 (Pubitemid 34969025)
17. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB (2004) Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 279:1615-1620. doi:10.1074/jbc. M306976200 (Pubitemid 38084426)
18. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM, CAPTURE Study Investigators (2003) Serum level of the anti-inflammatory cytokine interleukin- 10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107:2109-2114. doi:10.1161/ 01.CIR.0000065232.57371.25 (Pubitemid 36532192)
19. Hua Y, Zhang Y, Ceylan-Isik AF, Wold LE, Nunn JM, Ren J (2011) Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy. Basic Res Cardiol 106:1173-1191. doi:10.1007/ s00395-011-0222-8
20. Hu Y, Zhang H, Lu Y, Bai H, Xu Y, Zhu X, Zhou R, Ben J, Xu Y, Chen Q (2011) Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization. Basic Res Cardiol 106:1311-1328. doi:10.1007/s00395-011-0204-x
21. Li S, Zhong S, Zeng K, Luo Y, Zhang F, Sun X, Chen L (2010) Blockade of NF-kappaB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats. Basic Res Cardiol 105:139-150. doi:10.1007/s00395-009-0067-6
22. Li Y, Jia Y, Pichavant M, Loison F, Sarraj B, Kasorn A, You J, Robson BE, Umetsu DT, Mizgerd JP, Ye K, Luo HR (2009) Targeted deletion of tumor suppressor PTEN augments neutrophil function and enhances host defense in neutropenia-associated pneumonia. Blood 113:4930-4941. doi:10.1182/blood-2008- 06- 161414
23. Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, Speirs HJ, Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du XJ, McMullen JR (2010) PI3 K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3 K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 30:724-732. doi:10.1161/ATVBAHA.109.201988
24. Keyes KT, Xu J, Long B, Zhang C, Hu Z, Ye Y (2010) Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction. Am J Physiol 298:H1198-H1208. doi:10.1152/ajpheart. 00915.2009
25. Kleinbongard P, Heusch G, Schulz R (2010) TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127:295-314. doi:10.1016/j.pharmthera.2010. 05.002
26. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R (2009) IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 104:e9-e18. doi: 10.1161/CIRCRESAHA.108.188243
27. Kwak YG, Song CH, Yi HK, Hwang PH, Kim JS, Lee KS, Lee YC (2003) Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 111:1083-1092. doi:10.1172/JCI16440 (Pubitemid 36397485)
28. Miki T, Miura T, Tanno M, Nishihara M, Naitoh K, Sato T, Takahashi A, Shimamoto K (2007) Impairment of cardioprotective PI3 K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway. Basic Res Cardiol 102:163-170. doi:10.1007/s00395-006-0622-3 (Pubitemid 46189957)
29. Mocanu MM, Yellon DM (2007) PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? Br J Pharmacol 150:833-838. doi:10.1038/sj.bjp. 0707155 (Pubitemid 46536622)
30. Moore KW, de Waal MalefytR, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765. doi:10.1146/annurev.immunol.19.1.683 (Pubitemid 32368050)
31. Oudit GY, Kassiri Z, Zhou J, Liu QC, Liu PP, Backx PH, Dawood F, Crackower MA, Scholey JW, Penninger JM (2008) Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovasc Res 78:505-514. doi:10.1093/cvr/cvn041 (Pubitemid 351769769)
32. Patten RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, Smith JJ, Mendelsohn ME, Konstam MA (1998) Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol 274:H1812-H1820
33. Pengal RA, Ganesan LP, Wei G, Fang H, Ostrowski MC, Tridandapani S (2006) Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. Mol Immunol 43:1557-1564. doi:10.1016/j.molimm. 2005.09.022
34. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E (1979) Myocardial infarct size and ventricular function in rats. Circ Res 44:503-512. doi:10.1016/ 0002-9149(79)90234-0 (Pubitemid 10200710)
35. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96:1563-1568. doi:10.1073/pnas.96.4.1563 (Pubitemid 29098491)
36. Poitz DM, Augstein A, Weinert S, Braun-Dullaeus RC, Strasser RH, Schmeisser A (2011) OxLDL and macrophage survival: essential and oxygen-independent involvement of the Hif-pathway. Basic Res Cardiol 106:761-772. doi:10.1007/s00395-011- 0186-8
37. Ruan H, Li J, Ren S, Gao J, Li G, Kim R, Wu H, Wang Y (2009) Inducible and cardiac specific PTEN inactivation protects ischemia/ reperfusion injury. J Mol Cell Cardiol 46:193-200. doi: 10.1016/j.yjmcc.2008.10.021
38. SaraivaM,O'Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181. doi:10.1038/nri2711
39. Schabbauer G, Matt U, Günzl P, Warszawska J, Furtner T, Hainzl E, Elbau I, Mesteri I, Doninger B, Binder BR, Knapp S (2010) Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia. J Immunol 185:468-476. doi:10.4049/jimmunol.0902221
40. Schulz R, Heusch G (2009) Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction? Circulation 119:1355-1357. doi:10.1161/CIRCULATIONAHA.108. 846105
41. Schwartzbauer G, Robbins J (2001) The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem 276:35786-35793. doi:10.1074/jbc.M102479200
42. Siddall HK, Warrell CE, Yellon DM, Mocanu MM (2008) Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3 K, using a congenital model of PTEN haploinsufficiency. Basic Res Cardiol 103:560-568. doi:10.1007/s00395-008-0735-y
43. Siragusa M, Katare R, Meloni M, Damilano F, Hirsch E, Emanueli C, Madeddu P (2010) Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice. Circ Res 106:757-768. doi: 10.1161/CIRCRESAHA.109.207449
44. Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G (2007) Bidirectional role of tumor necrosis factoralpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 100:140-146. doi:10.1161/01.RES.0000255031.15793. 86 (Pubitemid 46066782)
45. Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87:1285-1342. doi:10.1152/physrev.00012.2007 (Pubitemid 350041472)
46. Staples KJ, Smallie T, Williams LM, Foey A, Burke B, Foxwell BM, Ziegler-Heitbrock L (2007) IL-10 induces IL-10 in primary human monocyte-derived macrophages via the transcription factor Stat3. J Immunol 178:4779-4785 (Pubitemid 46595259)
47. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'Shea JJ, Hunter CA (2007) Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8:1363-1371. doi:10.1038/ni1537 (Pubitemid 350131173)
48. Stumpf C, Seybold K, Petzi S, Wasmeier G, Raaz D, Yilmaz A, Anger T, Daniel WG, Garlichs CD (2008) Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction. Eur J Heart Fail 10:733-739. doi:10.1016/j.ejheart.2008.06.007
49. Sun M, Dawood F, Wen WH, Chen M, Dixon I, Kirshenbaum LA, Liu PP (2004) Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 110:3221-3228. doi: 10.1161/01.CIR.0000147233.10318.23 (Pubitemid 39525069)
50. Tankersley CG, Champion HC, Takimoto E, Gabrielson K, Bedja D, Misra V, El-Haddad H, Rabold R, Mitzner W (2008) Exposure to inhaled particulate matter impairs cardiac function in senescent mice. Am J Physiol 295:R252-R263. doi:10.1152/ajpregu.00697.2007
51. Thielmann M, Dörge H, Martin C, Belosjorow S, Schwanke U, van De Sand A, Konietzka I, Büchert A, Krüger A, Schulz R, Heusch G (2002) Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. Circ Res 90:807-813. doi:10.1161/01.RES.0000014451.75415.36 (Pubitemid 34633897)
52. Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, Doevendans PA, van Echteld CJ, Joles JA, Quax PH, Piek JJ, Pasterkamp G, de Kleijn DP (2008) Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 102:257-264. doi:10.1161/CIRCRESAHA.107.158220 (Pubitemid 351674064)
53. Yang Z, Zingarelli B, Szabó C (2000) Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury.Circulation 101:1019-1026. doi:10.1161/01.CIR.101.9.1019
54. Zhou JH, Broussard SR, Strle K, Freund GG, Johnson RW, Dantzer R, Kelley KW (2001) IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 30-kinase. J Immunol 167:4436-4442 (Pubitemid 32954321)
55. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, Cicchitelli G, Olivares A, Parrinello G, Percoco G, Guardigli G, Mele D, Pirani R, Ferrari R (2005) Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 111:863-870. doi:10.1161/01.CIR.0000155614.35441.69 (Pubitemid 40279887)
56. Zu L, Bedja D, Fox-Talbot K, Gabrielson KL, Van Kaer L, Becker LC, Cai ZP (2010) Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice. J Mol Cell Cardiol 49:5-15. doi:10.1016/j.yjmcc.2010.02. 007
57. Zu L, Zheng X, Wang B, Parajuli N, Steenbergen C, Becker LC, Cai ZP (2011) Ischemic preconditioning attenuates mitochondrial localization of PTEN induced by ischemia-reperfusion. Am J Physiol 300:H2177-H2186. doi:10.1152/ajpheart.01138.2010